We have located links that may give you full text access.
Case Reports
Journal Article
Medullary Thyroid Cancer: Overview and Case Study of a Rare Cancer
Clinical Journal of Oncology Nursing 2018 April 2
BACKGROUND: Medullary thyroid cancer (MTC) is a rare cancer that has historically been managed by endocrinologists. In 2011, the first of several multi- targeted tyrosine kinase inhibitors was approved as treatment for MTC. These drugs have changed the management of MTC to teams that include oncologists and oncology nurses.
OBJECTIVES: This article illustrates MTC diagnostics, surveillance, management of adverse drug reactions, and disease progression through a case study.
METHODS: An overview of MTC is offered, followed by an in-depth case study that examines MTC from the patient's perspective.
FINDINGS: Oncology nurses can influence patient outcomes through the provision of patient education, support, and management of disease and treatment complications.
OBJECTIVES: This article illustrates MTC diagnostics, surveillance, management of adverse drug reactions, and disease progression through a case study.
METHODS: An overview of MTC is offered, followed by an in-depth case study that examines MTC from the patient's perspective.
FINDINGS: Oncology nurses can influence patient outcomes through the provision of patient education, support, and management of disease and treatment complications.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app